Log in to save to my catalogue

Safety and Immunogenicity of 2009 pH1N1 Vaccination in HIV-Infected Pregnant Women

Safety and Immunogenicity of 2009 pH1N1 Vaccination in HIV-Infected Pregnant Women

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3634309

Safety and Immunogenicity of 2009 pH1N1 Vaccination in HIV-Infected Pregnant Women

About this item

Full title

Safety and Immunogenicity of 2009 pH1N1 Vaccination in HIV-Infected Pregnant Women

Publisher

Oxford: Oxford University Press

Journal title

Clinical infectious diseases, 2013-05, Vol.56 (10), p.1488-1497

Language

English

Formats

Publication information

Publisher

Oxford: Oxford University Press

More information

Scope and Contents

Contents

Background. Pregnant women infected with human immunodeficiency virus (HIV) may have particular vulnerability to 2009 pandemic H1N1 influenza (pH1N1) infection. The safety and immunogenicity of pH1N1 vaccination in HIV-infected pregnant women are unknown. Methods. HIV-infected women 18–39 years of age and 14–34 weeks' gestation on antiretroviral th...

Alternative Titles

Full title

Safety and Immunogenicity of 2009 pH1N1 Vaccination in HIV-Infected Pregnant Women

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3634309

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3634309

Other Identifiers

ISSN

1058-4838

E-ISSN

1537-6591

DOI

10.1093/cid/cit057

How to access this item